Monashee Investment Management LLC Intellia Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

  • $673 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$46.59 - $83.68 $1.16 Million - $2.09 Million
-25,000 Closed
0 $0
Q4 2020

Feb 11, 2021
BUY
$18.83 - $63.53 $470,749 - $1.59 Million
25,000 New
25,000 $1.36 Million
Q3 2020

Nov 13, 2020
SELL
$17.47 - $24.93 $1.92 Million - $2.74 Million
-110,000 Closed
0 $0
Q2 2020

Aug 11, 2020
BUY
$11.14 - $22.87 $1.23 Million - $2.52 Million
110,000 New
110,000 $2.31 Million

Others Institutions Holding NTLA

# of Institutions
334
Shares Held
95.3M
Call Options Held
1.06M
Put Options Held
863K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $550M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email